Searched for
PHARMACEUTICAL INDUSTRY UPDATES
Madhusudan Kela-backed fund buys stake in IPO-bound Steamhouse India for Rs 40 croreAce investor Madhusudan Kela's funds, along with Niveshaay Sambhav Fund, have injected Rs 49.99 crore into Steamhouse India via a pre-IPO p...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 24%When business updates start to come in or when some FMCG or auto companies indicate that things are not all good in the rural space, we may...
- Over 60% of pharma MSMEs yet to comply with updated manufacturing normsPharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...
- Piyush Goyal engages with over 50 industry leaders in New York to deepen India-US tradeIndia and the United States moved closer to deepening their trade ties as Union Minister of Commerce and Industry Piyush Goyal engaged with...
- India, Japan discuss steps to fix energy supply disruptionsIndia and Japan are addressing disruptions in energy supply chains and maritime connectivity. External Affairs Minister S Jaishankar met hi...
- From axles to rare earth: India draws up list of 100 products it still can't make enough ofIndia is set to boost its manufacturing sector by identifying around 100 products for domestic production. This initiative aims to reduce r...
- Drugmakers must report safety data from launch date, not approval date: CDSCOIndia's drug regulator has issued a new directive for pharmaceutical companies. Periodic Safety Update Reports for new drugs must now be su...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is not every day that you see crude oil prices moving higher and the Asian markets, including India, also inching higher. Now, as an inv...
- Stocks in news: RIL, IDFC First Bank, Paytm, Sun Pharma, Manappuram FinanceIndian markets faced pressure extending a corrective phase. Key companies like RIL, IDFC First Bank, and Paytm reported their financial res...
- US to loosen marijuana rules in major shift for $47 billion industryThe United States Department of Justice is easing rules on certain marijuana items. The drug will be reclassified as less dangerous. This s...
- Erring drug companies to face stricter action as rules to improve mfg standards come into effect todayDrugmakers in India may soon face stricter enforcement of quality standards. The revised Schedule M, which details manufacturing practices ...
- Regulatory, policy reforms crucial for future of India's pharma R&D: ReportIndia's regulatory and policy reforms are crucial for the future of pharmaceutical R&D, streamlining approval processes and strengthening I...
- How to reskill and upskill yourself in pharma industryThe Indian pharma sector is evolving rapidly, demanding reskilling amidst technological advancements and regulatory shifts. To thrive, prof...
- Pharmaceutical bodies welcome uniform marketing code"We welcome the UCPMP. It is a balanced order that ensures that there is a healthy and ethical engagement between the pharmaceutical indust...
- Ashok Leyland, Samvardhana Motherson among 8 BSE midcap stocks which hit new 52-week highAfter its Q1 results, Ashok Leyland achieved a new 52-week high at Rs. 183.25 on July 21, 2023. As a major player in the automotive industr...
- Domestic pharma firms should focus on development of innovative products: Mansukh Mandaviya"We are there in terms of volumes with generic products. We are already exporting medications in containers. I wish the industry in the com...
- European Union unveils plan to cut dependency on China, othersThe 27-nation bloc outlined the urgency of the task citing Europe's reliance on China for about half of 137 products used in sensitive ecos...
- Extensive hiring freeze, delayed onboarding imminent: SurveyThe survey had responses from 195 cos spanning a number of sectors like IT, manufacturing & banking.
- No shortage of APIs and formulations in the country: GovtNPPA has informed that it has not received any reference from pharma associations regarding steep increase in price of medicines due to out...
Load More
